Clinical trialNCT06706817Active, not recruitingPhase 3Interventional

A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab

SponsorAstraZenecaEnrollment181Chronic Rhinosinusitis With Nasal Polyps

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Enrico Heffler, MD, PhD
Associate Professor of Internal Medicine and Consultant at the Personalized Medicine, Asthma and Allergy Unit at IRCCS Humanitas Research Hospital
Principal Investigator
clinicaltrials.gov ↗
Tanya M Laidlaw, MD
Director of Translational Research in Allergy and Director of the Aspirin-Exacerbated Respiratory Disease (AERD) Centre at the Brigham and Women's Hospital.
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bulgaria

Research Site
Plovdiv, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria

Canada

Research Site
Hamilton, Ontario, Canada
Research Site
Québec, Quebec, Canada
Research Site
Québec, Quebec, Canada

France

Research Site
Le Kremlin-Bicêtre, France
Research Site
Marseille, France
Research Site
Nantes, France
Research Site
Pierre-Bénite, France
Research Site
Poitiers, France
Research Site
Toulouse, France

Germany

Research Site
Marburg, Germany
Research Site
Tübingen, Germany
Research Site
Villingen-Schwenningen, Germany
Research Site
Wiesbaden, Germany

Hungary

Research Site
Budapest, Hungary
Research Site
Budapest, Hungary
Research Site
Nyíregyháza, Hungary
Research Site
Pécs, Hungary

Italy

Research Site
Bologna, Italy
Research Site
Catania, Italy
Research Site
Florence, Italy
Research Site
Padua, Italy
Research Site
Pisa, Italy
Research Site
Roma, Italy
Research Site
Rozzano, Italy

Poland

Research Site
Bialystok, Poland
Research Site
Bydgoszcz, Poland
Research Site
Lodz, Poland
Research Site
Zawadzkie, Poland

Spain

Research Site
Barcelona, Spain
Research Site
Barcelona, Spain
Research Site
Cadiz, Spain
Research Site
Madrid, Spain
Research Site
Salamanca, Spain
Research Site
Santiago de Compostela, Spain

United States

Research Site
Newport Beach, California, United States
Research Site
Chicago, Illinois, United States
Research Site
Chestnut Hill, Massachusetts, United States

1 more site on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 3 Dec 2024
Primary completion: 13 Jan 2027
Completion: 13 Jan 2027
Last update posted: 10 Jun 2026
Registered enrollment: 181
Registry id: NCT06706817

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.